Morepen Labs Re-appoints Vijender Sharma & Co as Cost Auditors

Morepen Laboratories Ltd's board re-appointed M/s. Vijender Sharma & Co. as Cost Auditors for the financial year ending March 31, 2027, following the Audit Committee's recommendation. This decision complies with the Companies Act, 2013 and related rules. The board also approved the second addendum to the Business Transfer Agreement with its subsidiary, Morepen Medipath Limited, revising the 'Appointed Date' to April 1, 2026. Additionally, the board recommended a final dividend of ₹0.20 per equity share for FY26, subject to shareholder approval.